<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001665124</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001806310</issuerCik>
      <issuerName>Taysha Gene Therapies, Inc.</issuerName>
      <secFileNumber>001-39536</secFileNumber>
      <issuerAddress>
        <com:street1>3000 PEGASUS PARK DRIVE</com:street1>
        <com:street2>SUITE 1430</com:street2>
        <com:city>DALLAS</com:city>
        <com:stateOrCountry>TX</com:stateOrCountry>
        <com:zipCode>75247</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(214) 612-0000</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Nagendran Sukumar</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Avenue</com:street1>
          <com:street2>4th Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>200000</noOfUnitsSold>
      <aggregateMarketValue>926000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>287000000</noOfUnitsOutstanding>
      <approxSaleDate>04/10/2026</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>01/02/2024</acquiredDate>
      <natureOfAcquisitionTransaction>RSU Grant</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Taysha Gene Therapies, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>131550</amountOfSecuritiesAcquired>
      <paymentDate>01/02/2024</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>01/02/2025</acquiredDate>
      <natureOfAcquisitionTransaction>RSU Grant</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Taysha Gene Therapies, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>49429</amountOfSecuritiesAcquired>
      <paymentDate>01/02/2025</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>01/02/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Option Grant</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Taysha Gene Therapies, Inc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>19021</amountOfSecuritiesAcquired>
      <paymentDate>01/02/2024</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Sukumar Nagendran</name>
        <address>
          <com:street1>3000 PEGASUS PARK DRIVE</com:street1>
          <com:street2>SUITE 1430</com:street2>
          <com:city>DALLAS</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>75247</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>01/12/2026</saleDate>
      <amountOfSecuritiesSold>200000</amountOfSecuritiesSold>
      <grossProceeds>942740.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 6/11/2025 and all representations regarding material non-public information were made as of the adoption of the plan.</remarks>
    <noticeSignature>
      <noticeDate>04/10/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>06/11/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>Sukumar Nagendran</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
